US AIDS Group Hails Brazil for Breaking Merck’s AIDS Drug Patent

Brazil produces some of its own AIDS drugs AIDS Healthcare Foundation (AHF), the US' largest provider of HIV/AIDS healthcare, education and prevention hailed the news that the President of Brazil, Luiz Inácio Lula da Silva, signed today a compulsory license for Merck's HIV/AIDS drug Efavirenz, freeing the country to buy a generic formula of the medication or produce it in its all state laboratories.

AHF also operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia. For them, Lula's move is seen as a victory for global AIDS activism and AIDS patients worldwide.

President Lula de Silva's decision comes after reports of a breakdown in negotiations between Brazil and the New Jersey based drug giant Merck. According to the country's health ministry, Brazil had asked Merck to cut the price of Efavirenz to 65 cents a pill from $1.57 and Merck had refused.

Brazil's decision to issue a compulsory license for the drug, which will allow the country to manufacture the drug or to buy generic versions, comes on the heels of Thailand's recent move to issue a compulsory license for Abbott's AIDS drug, Kaletra and in the lead-up to an AIDS Healthcare Foundation-hosted discussion regarding AIDS drug-pricing for Mexico, scheduled for June 4th in Mexico City.

"In announcing its intention to issue a compulsory license for Merck's AIDS drug Efavirenz, Brazil is once again leading the way to affordable AIDS drug access for every nation," added Michael Weinstein, President of AIDS Healthcare Foundation.

"We salute the courage of countries such as Brazil, Thailand and Mexico who are fighting to ensure drug access for AIDS patients the world over. Today is a victory for AIDS activists and patients everywhere, and proof that drug companies will go down in defeat every time they place themselves in the way of justice for AIDS patients."

Flexibilities under the World Trade Organization's (WTO) Trade-related Aspects of Intellectual Property Rights (TRIPS) Agreement allow governments to issue compulsory licenses (including royalty payment to the patent owner) if the country deems it necessary and appropriate to protect the health of its citizens.

Brazil has been widely praised by global AIDS treatment activists for its government AIDS program, which provides free medication for anyone who needs it.

In the Latin American region, AIDS Healthcare Foundation operates free HIV/AIDS treatment clinics in Guatemala (Quetzaltenango) and in Mexico (Tijuana and Puerto Vallarta).

Tags:

You May Also Like

Santa Catarina, Brazil, Sells Mercosur US$ 207 Million But Buys US$ 307 Million

Exports from the southern Brazilian state of Santa Catarina to the Mercosur, a customs ...

Brazilian Indian Women Raped While Waiting to Get Land Back

Two old Indian women from the Guarani people, in Brazil, were raped by security ...

Brazil Wants Much More than Current 1% of China’s Pie

Brazil hopes to augment its trade with China to US$ 10 billion in 2005. ...

A street market in Brazil

I Can’t Help It! I’m Already Missing Brazil.

I live in São Paulo, but I return to the "Estados Unidos" (USA) twice ...

Brazil Strategy Network

US-Brazil Group to Focus on Civil Society in National Meeting in NY

The Brazil Strategy Network (BSN) will hold its fourth annual National Meeting on Saturday, ...

Brazil Ethanol Has Become too Expensive to Compete with Gasoline

Brazil’s Única, the sugarcane grower and mill owner association, tells us that over the ...

Soy Cultivation Is Bearing Slavery in Brazil, Says Report

The report "Eating the Amazon," released by the Greenpeace International non-government organization shows that, ...

Brazil Tries to Sell New Trade Image, Beyond Raw Material

There is a need for Brazil to promote its goods overseas. Although trade has ...

Venezuela’s Deals Are Too Good to Pass, But Brazil Has Been Resisting

While crowds of cheering supporters gathered outside the National Assembly in Venezuela on August ...

Drop in Oil Prices Bring Modest Gains to Brazil

Latin American markets were mixed, on Monday, November 7, with Mexican and Brazilian shares ...